These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7110471)

  • 1. The toxicity of guanidino compounds in the red blood cell in uremia and the effects of hemodialysis.
    Shainkin-Kestenbaum R; Giat Y; Berlyne GM
    Nephron; 1982; 31(1):20-3. PubMed ID: 7110471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hemodialysis on guanidinopropionic acid metabolism.
    Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
    Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
    Rocić B; Breyer D; Granić M; Milutinović S
    Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transketolase activity and guanidino compounds in hemodialysis patients.
    Pietrzak I; Baczyk K
    Kidney Int Suppl; 2001 Feb; 78():S97-101. PubMed ID: 11168992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate-cyanide test on red blood cells in uremia: effect of guanidinopropionic acid.
    Kamoun PP; Zingraff JJ; Turlin G; Lebreton P
    Nephron; 1981; 28(1):26-9. PubMed ID: 7266724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
    De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
    Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential removal of guanidinosuccinic acid and creatine by hemodialysis and continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Billiouw JM; Becaus I; Lornoy W
    Nephron; 1991; 57(3):369-70. PubMed ID: 2017282
    [No Abstract]   [Full Text] [Related]  

  • 15. The presence and toxicity of guanidinoproprionic acid in uremia.
    Shainkin R; Giatt Y; Berlyne GM
    Kidney Int Suppl; 1975 Feb; (3):302-5. PubMed ID: 1057703
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the effect of low-molecule uremic toxins on the activity of glucose-6-phosphate dehydrogenase (E.C.1.1.1.49) and transketolase (E.C.2.2.1.1) in human red blood cells.
    Kopczyński Z; Dryl-Rydzyńska T
    Acta Physiol Pol; 1988; 39(4):269-75. PubMed ID: 3252690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatographic determination of guanidino compounds in uremic patients using glyoxal as derivatizing reagent.
    Majidano SA; Khuhawar MY
    J Chromatogr Sci; 2012 May; 50(5):380-6. PubMed ID: 22392369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of creatine and beta-guanidinopropionic acid on the growth of Ehrlich ascites tumor cells: i.p. injection and culture study.
    Ohira Y; Inoue N
    Biochim Biophys Acta; 1995 Apr; 1243(3):367-72. PubMed ID: 7727511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents.
    Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M
    Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.